INTRODUCTION
Anterior uveitis is the most common form of intraocular inflammation of the Uveal tissue from Iris upto the Pars-plicate of Ciliary body that affects the individual with significant distress and potentially long lasting sight threatening complications.
[1]
The prevalence of uveitis which was estimated to be around 17.4 per 100,000 in 1960's, in a more recent investigations has been reported to be 52.4 per 100,000 people and the incidence being uprising. This condition is typically characterised by photophobia, lacrimation, Blurred vision, Pain, Ciliary congestion, Ocular tenderness, Keratic precipitates, aqueous flare and inflammatory cells that can be detected by slit lamp bio microscopy.
[2] Clinically it may present as Acute or chronic anterior uveitis. Theaetiology for the origin of this inflammatory process can be of Exogenous infection (Where in the infecting organisms directly gain entrance in to the eye from Outside), Endogenous infection (Caused by the entrance of organisms from some sources situated else where in the body, through blood stream, Immune related origin (due to Microbialallergy, Autoimmune reaction, Anaphylactic) or Idiopathic.
Inflammation of the uvea fundamentally has the same characteristic as any other tissue in the bodyAvascular and cellular response. Both eyes showed smooth, accurate, full and equal extraocular muscle movements in all fields of gaze. No pupillary defect was observed, and no notable photophobia was reported in either eye. Finger counting confrontation visual fields were full OD and OS.
Slit lamp Bio microscopy
Circum ciliary congestion was present in both the eyes, mild cellular deposits were seen on the back of the cornea, Anterior segment findings, demonstrated 1+ circumlimbal flush with trace of inflammatory cells and flare in OD and OS
Schiotz tonometry
IOP was 13 mmHg OD and 14 mmHg OS
Ophthalmoscopy examination
Showed a normal retina with healthy maculae and vasculature and normal optic cup-disc ratios with healthy optic nerve head rims and distinct disc margins in both eyes.
On the basis of clinical findings, the patient was diagnosed with recurrent, mild, chronic anterior uveitis of both the eyes and educated about his findings, prognosis and treatment options. The planning of treatment was done in the way such that therapies and medicaments had Shotaghna, Srotodusti Nirharana, Pitta Hara, Kaphahara and Chaksuhya properties.
Anterior uveitis is due to vitiation Tridosha predominantly Pitta Dosha and vitiation is because of a generalized pathology and not because of indigenous cause. Hence Kaya Shodhana becomes mandatory to eliminate the disease from the core.
As Ama Lakshanas were there Deepana & Pachana Karma was done with Chitrakadi Vati and Panchakola Choorna for 5 days.
In Snehapana, lipids are processed with medicine which are having the active ingredients that acts on the particular disorder by crossing the cell membrane. By this, the functions of phospholipids will increases the affinity of cellular elements or Doshas which are responsible for the formation of diseases and the lipids helps to loosen the pathogens which can be understood as Dosha Utkleshana. In this case Mahatrihala Ghrita is choosen to reach the target organ Chakshu as it is Chakshushya.
Abhyanga or external oleation and Swedana or sudation therapy helps to drain the impurities towards the gut, as well as in the form of excretion.
Virechana was the choice of Panchakarma in this patient as it is meant for Pitta and Kapha Dosha, which are also the components in pathogenesis in this condition. When the medicine is administered to the patient orally, after the complete digestion, the action of given medicine starts. The active ingredients of the medicine will stimulate the mucosal membrane and changes the normal permeability of mucosal lining temporarily, due to which the Doshas are transferred from cellular level to gut level with the help of Snehana and Swedana Karma are expelled out through Anal route.
Jaloukavacharana is having an important role in treating Pittaja and Raktaja Netra Rogas by doing Raktashodhana. When leaches are applied over the site they inject biologically active substances through saliva, Calin, Eglin have anti-inflammatory properties that helps in arresting inflammation, vasodilators like acetylcholine, histamine increases the blood flow at the affected area and during sucking of blood and hyaluronidase facilitates the penetration and diffusion of pharmacological active substances into the deeper tissue. Jaloukavacharana in Anterior uveitis not only accelerates the healing process, but also to avoid the recurrence and the formation of synechias. Thus the application of Jalouka in this case contributes to the rapid regression of signs and symptoms such as pain, redness, congestion and aqueous cells. The active principles like Catechins, quinines of Musta by enhancing phagocytosis acts as immune modulator, The bio active constituent Berberine present in Daruharidra also blocks the release of cytokines thereby by acting as anti-inflammatory and the Curcumin in Haridra inhibits the release of the pro-inflammatory cytokine TNF-α. Thereby the combination of these drugs helps in reducing the symptom of redness. The presence of different active components in Triphala such as Gallic acid, chebulic acid, ellagic acid, flavonoids, phenols responsible for effective immune stimulatory and immunosuppressant properties helps to improve immunity thus acted well in anterior uveitis.
CONCLUSION
Reducing the inflammation and Restoration of structural integrity in anterior uveitis was the objective of treatment in this case. Ayurveda treatment principles helped to arrest the rate of inflammation and to reduce the rate of reoccurrence which are evident by subsequent follow-ups. The treatment indicated in modern science have their own side-effects and reluctant to give promising results in the recurrence associated with compromised immunity. In Ayurveda, with the sound understand in of Samprapthi, Dosha involvement, which are pivotal for proper implication of Shodhana (detoxification) and Shamana (palliative) definitely have an upper hand in providing promising results. To further validate and standardise the treatment protocol a pilot study with different combination and a large sample study always holds good.
